Chung-Ming Hsieh

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
HARVARD UNIVERSITY
1
1995
Abbott Laboratories
1
1
2011
2012
ABBVIE DEUTSCHLAND GMBH & CO KG
4
2
2
3
1
2009
2011
2012
2015
2016
NUVOTON TECHNOLOGY CORPORATION
3
1
2016
2017
AGERE SYSTEMS GUARDIAN CORP.
1
1
2001
2002
AGERE SYSTEMS INC.
1
1
2
1
1
2000
2001
2002
2003
2004
BELL SEMICONDUCTOR, LLC
1
1
1
1
2000
2001
2002
2003
WELLS FARGO CAPITAL FINANCE, LLC
2
2013
BRISTOL-MYERS SQUIBB COMPANY
2
2009
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
1
1
1
2
2
1995
1997
1998
1999
2002
THE UNIVERSITY OF SHEFFIELD
1
2008
ABBVIE INC.
2
13
9
10
11
28
9
10
7
2007
2009
2010
2011
2012
2013
2014
2015
2016
ORIG3N, INC.
1
2
2002
2008
Analog Integrations Corporation
1
2010
LUCENT TECHNOLOGIES INC.
1
2000

Inventor Addresses

AddressDuration
Boston, MADec 08, 98 - Dec 08, 98
Cambridge, MAJul 28, 98 - Feb 13, 03
HSINCHU CITY, TWJun 08, 17 - Jun 08, 17
Hsin-Chu, TWApr 19, 12 - Apr 19, 12
Hsinchu Science Park, TWApr 04, 17 - Sep 05, 19
Hsinchu, TWFeb 20, 18 - Dec 10, 19
Jhubei City, TWJun 25, 20 - Jun 25, 20
Jhubei, TWMay 11, 21 - May 11, 21
NEWTON, MA, USOct 21, 10 - May 10, 18
Newton, MA, USOct 22, 09 - Jan 11, 24
Newtown, MA, USMar 19, 13 - Mar 04, 14
West Roxbury, MADec 25, 03 - Sep 02, 04
West Roxbury, MA, USNov 04, 10 - Nov 04, 10
Wyomissing, PAJul 31, 03 - Dec 16, 04
Zhubei City, TWOct 07, 21 - Oct 14, 21
Zhubei, TWApr 19, 22 - Apr 19, 22

Technology Profile

Technology Matters
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 67
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 16
C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 21

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2024/0011,0162024FULL-LENGTH HUMAN IMMUNOGLOBULIN G ANTIBODY LIBRARIES FOR SURFACE DISPLAY AND SECRETION IN SACCHAROMYCES CEREVISIAE0
2023/0272,0562023AFFINITY MATURED ANTI-LAP ANTIBODIES AND USES THEREOF0
2023/0265,1752023HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT SERINE 4130
117024672023High affinity antibodies targeting tau phosphorylated at serine 4130
2023/0167,1682023HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT SERINE 4130

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.